Pros, cons, and costs of INFUSE in spinal surgery

@inproceedings{Epstein2011ProsCA,
  title={Pros, cons, and costs of INFUSE in spinal surgery},
  author={Nancy Ellen Epstein},
  booktitle={Surgical neurology international},
  year={2011}
}
BACKGROUND INFUSE (recombinant human bone morphogenetic protein-2 [rh-BMP-2]; Medtronic, Memphis, TN, USA) is approved by the Federal Drug Administration (FDA) only for use with the lumbar tapered fusion device (LT Cage; Medtronic) to perform single-level anterior lumbar interbody fusions (ALIF: L2-S1 levels). INFUSE, however, is widely utilized in an "off-label" capacity for anterior and/or posterior cervical, thoracic, and lumbar surgery. Nevertheless, Medicare and other insurance companies… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Complications with rhBMP-2 in posterolateral spine fusion: A consecutive series of one thousand thirty-seven cases

SD Glassman, J Howard, +3 authors L. Carreon
Spine • 2010
View 11 Excerpts
Highly Influenced

High-dose bone morphogenetic protein-induced ectopic abdomen bone growth.

The spine journal : official journal of the North American Spine Society • 2010
View 11 Excerpts
Highly Influenced

surgery : A systematic review

K Owens, SD Glassman, +3 authors LY Carreon
2010

Similar Papers

Loading similar papers…